1. Home
  2. CRBU vs BW Comparison

CRBU vs BW Comparison

Compare CRBU & BW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • BW
  • Stock Information
  • Founded
  • CRBU 2011
  • BW 1867
  • Country
  • CRBU United States
  • BW United States
  • Employees
  • CRBU N/A
  • BW N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • BW Building Products
  • Sector
  • CRBU Health Care
  • BW Industrials
  • Exchange
  • CRBU Nasdaq
  • BW Nasdaq
  • Market Cap
  • CRBU 93.0M
  • BW 95.7M
  • IPO Year
  • CRBU 2021
  • BW N/A
  • Fundamental
  • Price
  • CRBU $1.62
  • BW $1.00
  • Analyst Decision
  • CRBU Strong Buy
  • BW Buy
  • Analyst Count
  • CRBU 4
  • BW 2
  • Target Price
  • CRBU $8.50
  • BW $3.50
  • AVG Volume (30 Days)
  • CRBU 1.9M
  • BW 876.9K
  • Earning Date
  • CRBU 08-05-2025
  • BW 08-07-2025
  • Dividend Yield
  • CRBU N/A
  • BW N/A
  • EPS Growth
  • CRBU N/A
  • BW N/A
  • EPS
  • CRBU N/A
  • BW N/A
  • Revenue
  • CRBU $9,918,000.00
  • BW $734,239,000.00
  • Revenue This Year
  • CRBU $9.52
  • BW $5.81
  • Revenue Next Year
  • CRBU N/A
  • BW $9.24
  • P/E Ratio
  • CRBU N/A
  • BW N/A
  • Revenue Growth
  • CRBU N/A
  • BW 12.90
  • 52 Week Low
  • CRBU $0.66
  • BW $0.22
  • 52 Week High
  • CRBU $3.00
  • BW $2.99
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 70.55
  • BW 51.93
  • Support Level
  • CRBU $1.62
  • BW $0.99
  • Resistance Level
  • CRBU $1.79
  • BW $1.10
  • Average True Range (ATR)
  • CRBU 0.12
  • BW 0.07
  • MACD
  • CRBU 0.03
  • BW -0.01
  • Stochastic Oscillator
  • CRBU 91.79
  • BW 44.12

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

Share on Social Networks: